Technical Analysis for BVX - BiVictriX Therapeutics Plc
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 11.25 | -4.26% | -0.50 |
BVX closed down 4.26 percent on Thursday, March 28, 2024, on 14 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Flat | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
Fell Below 50 DMA | Bearish | 0.00% | |
Expansion Pivot Sell Setup | Bearish Swing Setup | 0.00% | |
Hammer Candlestick | Bullish | 0.00% | |
Wide Range Bar | Range Expansion | 0.00% | |
BB Squeeze Ended | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
20 DMA Support | Bullish | -4.26% |
Alert | Time |
---|---|
Fell Below Previous Day's Low | about 7 hours ago |
Down 1% | about 7 hours ago |
Possible NR7 | about 7 hours ago |
Fell Below 20 DMA | about 7 hours ago |
Fell Below 10 DMA | about 7 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
BiVictriX Therapeutics Plc, a biotechnology company, engages in the development of cancer therapies in the United Kingdom. The company develops Bi-Cygni therapeutics, which are selective for cancer types. Its lead program is BVX001, focuses on acute myeloid leukaemia. The company was formerly known as BiVictriX Plc and changed its name to BiVictriX Therapeutics Plc in August 2021. BiVictriX Therapeutics Plc was founded in 2016 and is based in Manchester, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Cancer Therapies
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Cancer Therapies
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 19.2 |
52 Week Low | 9.0 |
Average Volume | 105,070 |
200-Day Moving Average | 13.11 |
50-Day Moving Average | 11.30 |
20-Day Moving Average | 11.65 |
10-Day Moving Average | 11.70 |
Average True Range | 0.45 |
RSI (14) | 24.24 |
ADX | 19.08 |
+DI | 9.42 |
-DI | 23.44 |
Chandelier Exit (Long, 3 ATRs) | 10.66 |
Chandelier Exit (Short, 3 ATRs) | 11.84 |
Upper Bollinger Bands | 11.94 |
Lower Bollinger Band | 11.36 |
Percent B (%b) | -0.19 |
BandWidth | 5.00 |
MACD Line | 0.05 |
MACD Signal Line | 0.10 |
MACD Histogram | -0.0437 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 12.83 | ||||
Resistance 3 (R3) | 12.75 | 12.15 | 12.56 | ||
Resistance 2 (R2) | 12.15 | 11.75 | 12.19 | 12.47 | |
Resistance 1 (R1) | 11.70 | 11.50 | 11.40 | 11.78 | 12.39 |
Pivot Point | 11.10 | 11.10 | 10.95 | 11.14 | 11.10 |
Support 1 (S1) | 10.65 | 10.70 | 10.35 | 10.73 | 10.11 |
Support 2 (S2) | 10.05 | 10.45 | 10.09 | 10.03 | |
Support 3 (S3) | 9.60 | 10.05 | 9.94 | ||
Support 4 (S4) | 9.68 |